Trial intelligence / Profile preview

Perioperative dexketamine in trauma surgery patients

ChiCTR2300069349Phase 4Not yet recruiting

Sponsor
Nanjing Drum-Tower Hospital
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of esketamine in acute pain and chronic stress (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Post Traumatic Stress Disorder Self-Rating Scale score. Planned start Mar 2023; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

acute painchronic stress

Beyond the preview

Go deeper on ChiCTR2300069349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300069349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call